Citrin deficiency presenting as acute liver failure in an eight-month-old infant

Mei-Hong Zhang1, Jing-Yu Gong1, Jian-She Wang1

  • 1Mei-Hong Zhang, Jing-Yu Gong, Department of Pediatrics, Jinshan Hospital, Fudan University, Shanghai 201508, China.

Insights

Citrin deficiency, a genetic disorder, can manifest as acute liver failure in infants, often triggered by infections. Early diagnosis and management, including specialized formulas and potential liver transplantation, are crucial for affected infants.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatric Gastroenterology

Background:

  • Citrin deficiency is a genetic disorder typically presenting with neonatal intrahepatic cholestasis.
  • The condition is caused by mutations in the SLC25A13 gene, affecting the mitochondrial aspartate-glutamate carrier protein.

Observation:

  • A previously healthy 8-month-old infant developed acute liver failure following a bronchial pneumonia infection.
  • Clinical presentation included jaundice, elevated bilirubin and ammonia, and coagulopathy.
  • Plasma amino acid analysis revealed elevated levels of tyrosine, methionine, citrulline, and arginine.

Findings:

  • Genomic DNA analysis confirmed a mutation (IVS16ins3kb) in SLC25A13, diagnosing citrin deficiency.
  • Despite immediate treatment with a specialized formula and ursodeoxycholic acid, cholestasis and abnormal laboratory indices persisted.

Implications:

  • This case highlights that citrin deficiency can present atypically as acute liver failure in late infancy, often precipitated by infection.
  • The findings underscore the importance of considering citrin deficiency in infants with unexplained acute liver failure.
  • Liver transplantation may be a necessary intervention for severe cases of citrin deficiency presenting with acute liver failure.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
261
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.5K
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
1.3K
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
593
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
346
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
5.0K